REG - IMI PLC - Director/PDMR Shareholding

IMIAnnouncement

21/11/2019 08:15

RNS Number : 1931U
IMI PLC
21 November 2019
 


21 November 2019
IMI plc

(the "Company")
Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them
This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:



1.


Details of the person discharging managerial responsibilities/ person closely associated




a)


Name


Daniel Shook




2.


Reason for the notification




a)


Position/status


Chief Financial Officer




b)


Initial notification/ Amendment


Initial Notification




3.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


IMI plc




b)


LEI


2138002W9Q21PF751R30




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument



  Identification code


Ordinary share



 

GB00BGLP8L22




b)


Nature of the transaction


Exercise of options granted in 2016 under the IMI Sharesave Plan




 c)


Price(s) and volume(s)


Price(s)


Volume(s)




£8.4510


2129




d)


Aggregated information
·      Aggregated volume
·      Price


N/A Single transaction




e)


Date of the transaction


20 November 2019




f)


Place of the transaction


London Stock Exchange Main Market (XLON)

























 
For further information, please contact:
John O'Shea

Group Legal Director and Company Secretary

Telephone: 0121 717 3700




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUSAFFUSESF